PDXP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.683400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.871000E-01
Normal-vs-Stage2
4.605200E-01
Normal-vs-Stage3
2.907400E-01
Normal-vs-Stage4
6.229400E-01
Stage1-vs-Stage2
2.187000E-01
Stage1-vs-Stage3
1.605960E-01
Stage1-vs-Stage4
2.390200E-01
Stage2-vs-Stage3
4.597200E-01
Stage2-vs-Stage4
9.268400E-01
Stage3-vs-Stage4
3.640400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.501000E-01
Normal-vs-AfricanAmerican
7.144200E-01
Normal-vs-Asian
5.372000E-01
Caucasian-vs-AfricanAmerican
7.880400E-01
Caucasian-vs-Asian
1.468120E-02
AfricanAmerican-vs-Asian
2.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.997200E-01
Normal-vs-Female
9.270400E-01
Male-vs-Female
7.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.214800E-01
Normal-vs-Age(41-60Yrs)
8.567200E-01
Normal-vs-Age(61-80Yrs)
9.947800E-01
Normal-vs-Age(81-100Yrs)
5.308000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.849600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.456600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.582200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.696400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.404400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.887600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.474000E-01
Normal-vs-Daily Drinker
6.731400E-01
Normal-vs-Weekly Drinker
9.577400E-01
Normal-vs-Occasional Drinker
7.027400E-01
Normal-vs-Social Drinker
8.712600E-01
Non Drinker-vs-Daily Drinker
1.329440E-01
Non Drinker-vs-Weekly Drinker
2.835800E-01
Non Drinker-vs-Occasional Drinker
1.158020E-01
Non Drinker-vs-Social Drinker
1.885200E-01
Daily Drinker-vs-Weekly Drinker
7.086400E-01
Daily Drinker-vs-Occasional Drinker
2.327000E-01
Daily Drinker-vs-Social Drinker
4.516200E-01
Weekly Drinker-vs-Occasional Drinker
3.696000E-01
Weekly Drinker-vs-Social Drinker
7.124400E-01
Occasional Drinker-vs-Social Drinker
5.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.305000E-01
Normal-vs-Grade 2
6.202800E-01
Normal-vs-Grade 3
5.988000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.949610E-02
Grade 1-vs-Grade 3
1.201790E-02
Grade 1-vs-Grade 4
9.305000E-01
Grade 2-vs-Grade 3
1.547750E-01
Grade 2-vs-Grade 4
6.202800E-01
Grade 3-vs-Grade 4
5.988000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.205600E-01
Normal-vs-NonDiabetic
8.794400E-01
Diabetic-vs-NonDiabetic
7.338200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.021000E-01
Normal-vs-NoPancreatitis
9.157000E-01
Pancreatitis-vs-NoPancreatitis
3.881600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.474800E-01
Normal-vs-N1
5.368400E-01
N0-vs-N1
6.510400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.222200E-01
Normal-vs-TP53-NonMutant
6.629000E-01
TP53-Mutant-vs-TP53-NonMutant
4.399200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
